Global Buccal Drug Delivery System Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

Description

List of Tables

The global demand for Buccal Drug Delivery System Market is presumed to reach the market size of nearly USD 8.41 Billion by 2032 from USD 4.7 Billion in 2023 with a CAGR of 6.68% under the study period 2024-2032.

The buccal drug delivery system refers to administering medications through the mucosal lining of the cheek or the floor of the mouth. This route allows drugs to bypass the gastrointestinal tract and liver metabolism, potentially improving bioavailability and therapeutic efficacy. Buccal delivery systems come in various forms, including patches, tablets, and films, designed to adhere to the buccal mucosa and release medications for absorption directly into the bloodstream.

MARKET DYNAMICS

The buccal drug delivery system market is poised for significant growth driven by several factors. Firstly, patient preference for non-invasive drug delivery methods, coupled with the ease of administration and improved patient compliance, boosts the adoption of buccal delivery systems. Pharmaceutical companies are increasingly spending R&D to develop novel formulations that enhance drug absorption and duration of action. Moreover, the potential for delivering small molecules and biologics through the buccal route expands the application scope across various therapeutic areas, including pain management, hormonal therapies, and neurological disorders. Furthermore, advancements in formulation technologies such as mucoadhesive polymers and permeation enhancers contribute to the market's expansion by overcoming barriers to drug absorption and improving therapeutic outcomes. Regulatory agencies' growing acceptance of buccal drug delivery systems as effective and safe alternatives to traditional routes further catalyzes market growth.

Moreover, the aging population and the rising prevalence of chronic diseases worldwide drive the demand for innovative drug delivery solutions that offer enhanced efficacy and reduced side effects. Additionally, partnerships between pharmaceutical companies and research institutions facilitate the development of customized buccal formulations tailored to specific patient needs, fostering market growth through product differentiation and expanded market penetration. However, stringent regulatory requirements and challenges in achieving consistent drug absorption rates across patient populations can hamper buccal drug delivery system market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Buccal Drug Delivery System. The growth and trends of Buccal Drug Delivery System industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Buccal Drug Delivery System market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Type

Sublingual Films and Wafers
Buccal Tablets/Lozenges
Oral Sprays

By Application

Pain Management
Smoking Cessation
Angina Pectoris
Others

By End-use

Hospitals
Ambulatory Centers
Others (Clinics, Home Health/OTC)

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Buccal Drug Delivery System market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Buccal Drug Delivery System market include GSK Plc, Teva Pharmaceutical Industries Ltd., Pfizer Inc., Generex Biotechnology Corporation (Lumitos AG), ARx LLC., Endo Inc., Catalent Inc, Cynapsus Therapeutics Inc., Collegium Pharmaceutical, Indivior PLC. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

Product Code: VMR112115326

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. BUCCAL DRUG DELIVERY SYSTEM - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Type
- 3.7.2 Market Attractiveness Analysis By Application
- 3.7.3 Market Attractiveness Analysis By End-use
- 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL BUCCAL DRUG DELIVERY SYSTEM MARKET ANALYSIS BY TYPE

5.1. Overview By Type
5.2. Historical and Forecast Data Analysis By Type
5.3. Sublingual Films and Wafers Historic and Forecast Sales By Regions
5.4. Buccal Tablets/Lozenges Historic and Forecast Sales By Regions
5.5. Oral Sprays Historic and Forecast Sales By Regions

6. GLOBAL BUCCAL DRUG DELIVERY SYSTEM MARKET ANALYSIS BY APPLICATION

6.1. Overview By Application
6.2. Historical and Forecast Data Analysis By Application
6.3. Pain Management Historic and Forecast Sales By Regions
6.4. Smoking Cessation Historic and Forecast Sales By Regions
6.5. Angina Pectoris Historic and Forecast Sales By Regions
6.6. Others Historic and Forecast Sales By Regions

7. GLOBAL BUCCAL DRUG DELIVERY SYSTEM MARKET ANALYSIS BY END-USE

7.1. Overview By End-use
7.2. Historical and Forecast Data Analysis By End-use
7.3. Hospitals Historic and Forecast Sales By Regions
7.4. Ambulatory Centers Historic and Forecast Sales By Regions
7.5. Others (Clinics, Home Health/OTC) Historic and Forecast Sales By Regions

8. GLOBAL BUCCAL DRUG DELIVERY SYSTEM MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1 Overview, Historic and Forecast Data Sales Analysis
- 8.3.2 North America By Segment Sales Analysis
- 8.3.3 North America By Country Sales Analysis
- 8.3.4 United States Sales Analysis
- 8.3.5 Canada Sales Analysis
- 8.3.6 Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1 Overview, Historic and Forecast Data Sales Analysis
- 8.4.2 Europe By Segment Sales Analysis
- 8.4.3 Europe By Country Sales Analysis
- 8.4.4 United Kingdom Sales Analysis
- 8.4.5 France Sales Analysis
- 8.4.6 Germany Sales Analysis
- 8.4.7 Italy Sales Analysis
- 8.4.8 Russia Sales Analysis
- 8.4.9 Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1 Overview, Historic and Forecast Data Sales Analysis
- 8.5.2 Asia Pacific By Segment Sales Analysis
- 8.5.3 Asia Pacific By Country Sales Analysis
- 8.5.4 China Sales Analysis
- 8.5.5 India Sales Analysis
- 8.5.6 Japan Sales Analysis
- 8.5.7 South Korea Sales Analysis
- 8.5.8 Australia Sales Analysis
- 8.5.9 South East Asia Sales Analysis
- 8.5.10 Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1 Overview, Historic and Forecast Data Sales Analysis
- 8.6.2 Latin America By Segment Sales Analysis
- 8.6.3 Latin America By Country Sales Analysis
- 8.6.4 Brazil Sales Analysis
- 8.6.5 Argentina Sales Analysis
- 8.6.6 Peru Sales Analysis
- 8.6.7 Chile Sales Analysis
- 8.6.8 Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1 Overview, Historic and Forecast Data Sales Analysis
- 8.7.2 Middle East & Africa By Segment Sales Analysis
- 8.7.3 Middle East & Africa By Country Sales Analysis
- 8.7.4 Saudi Arabia Sales Analysis
- 8.7.5 UAE Sales Analysis
- 8.7.6 Israel Sales Analysis
- 8.7.7 South Africa Sales Analysis
- 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE BUCCAL DRUG DELIVERY SYSTEM COMPANIES

9.1. Buccal Drug Delivery System Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10. COMPANY PROFILES OF BUCCAL DRUG DELIVERY SYSTEM INDUSTRY

10.1. Top Companies Market Share Analysis
10.2. Market Concentration Rate
10.3. GSK Plc
- 10.3.1 Company Overview
- 10.3.2 Company Revenue
- 10.3.3 Products
- 10.3.4 Recent Developments
10.4. Teva Pharmaceutical Industries Ltd.
- 10.4.1 Company Overview
- 10.4.2 Company Revenue
- 10.4.3 Products
- 10.4.4 Recent Developments
10.5. Pfizer Inc.
- 10.5.1 Company Overview
- 10.5.2 Company Revenue
- 10.5.3 Products
- 10.5.4 Recent Developments
10.6. Generex Biotechnology Corporation (Lumitos AG)
- 10.6.1 Company Overview
- 10.6.2 Company Revenue
- 10.6.3 Products
- 10.6.4 Recent Developments
10.7. ARx LLC.
- 10.7.1 Company Overview
- 10.7.2 Company Revenue
- 10.7.3 Products
- 10.7.4 Recent Developments
10.8. Endo Inc.
- 10.8.1 Company Overview
- 10.8.2 Company Revenue
- 10.8.3 Products
- 10.8.4 Recent Developments
10.9. Catalent Inc
- 10.9.1 Company Overview
- 10.9.2 Company Revenue
- 10.9.3 Products
- 10.9.4 Recent Developments
10.10. Cynapsus Therapeutics Inc.
- 10.10.1 Company Overview
- 10.10.2 Company Revenue
- 10.10.3 Products
- 10.10.4 Recent Developments
10.11. Collegium Pharmaceutical
- 10.11.1 Company Overview
- 10.11.2 Company Revenue
- 10.11.3 Products
- 10.11.4 Recent Developments
10.12. Indivior PLC
- 10.12.1 Company Overview
- 10.12.2 Company Revenue
- 10.12.3 Products
- 10.12.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies